Stay updated on Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The history adds a new site revision v3.6.6 and removes the previous v3.6.5, indicating an updated release of the page framework.
    Difference
    0.0%
    Check dated 2026-09-01T20:04:48.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Outcome Measures (Results), Contacts/Locations, and Study Status have been added, signaling a newer version of the record with expanded access to current results, contact points, and status. The update reflects an enhanced organization of core study information for easier review and coordination.
    Difference
    0.3%
    Check dated 2026-08-25T20:12:38.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page’s revision label in the footer changed from v3.6.4 to v3.6.5, reflecting a new build of the site. This update appears to affect only metadata and not study content or user tasks.
    Difference
    0.0%
    Check dated 2026-08-11T16:22:11.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 entry was added to the study record history. The previous Revision: v3.6.3 entry was removed.
    Difference
    0.0%
    Check dated 2026-07-28T05:17:35.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.6.3 instead of v3.6.2, signaling a new site release. There are no changes to the study records or page navigation reflected by this update.
    Difference
    0.0%
    Check dated 2026-07-06T15:50:13.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The revision badge on the page updated from v3.6.0 to v3.6.2, signaling a platform release. No study data or navigation elements appear to be changed.
    Difference
    0.0%
    Check dated 2026-06-29T08:54:03.000Z thumbnail image

Stay in the know with updates to Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.